AZD5004 / AstraZeneca, Eccogene  >>  Phase 1
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD5004 / AstraZeneca
NCT05654831: FTIH of ECC5004 in Healthy and Diabetic Participants

Completed
1
69
US
Placebo, ECC5004
Eccogene
Type 2 Diabetes Mellitus
11/23
11/23
NCT06268145: ECC5004 RBA FE Study in Healthy Participants

Completed
1
14
US
ECC5004
Eccogene
Type 2 Diabetes Mellitus
03/24
03/24
NCT06293742: ECC5004 DDI Study With Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy Participants

Completed
1
48
US
ECC5004, Midazolam, Rosuvastatin, Digoxin, Atorvastatin
Eccogene
Type 2 Diabetes Mellitus
04/24
04/24
NCT06555822: A Study to Investigate Multiple Ascending Doses of AZD5004 in Healthy Participants

Recruiting
1
15
US
AZD5004, ECC5004, Placebo
AstraZeneca
Healthy Participants
03/25
03/25

Download Options